Product Information
PHYTONADIONE 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $8.8257 per EA under NDC 69097099902. Its NADAC has been published 122 times since Jun 5, 2024.
FDA first approved this application on Jul 28, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097099902
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHYTONADIONEApproval Type
Generic (ANDA)
FDA Application
ANDA213329FDA Approved
7/28/2023
TE Code
AB
On Market Since
12/1/2023
Pharmacological Classes
Price Statistics
The NADAC for PHYTONADIONE 5 MG TABLET has been published 122 times since Jun 5, 2024, and over the history we have for it it has declined 60.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8257 per EA |
|---|---|
| All-time high | $22.5154 (Jun 12, 2024) |
| All-time low | $8.8257 (Sep 23, 2026) |
| 52-week high | $12.6526 |
| 52-week low | $8.8257 |
| Median price | $11.8169 |
| Average price | $12.2179 |
| Largest weekly change | -18.8% (Jul 17, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phytonadione market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin K class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHYTONADIONE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHYTONADIONE 5 MG TABLET, manufactured by Cipla USA Inc., is $8.8257 per EA (NDC 69097099902), effective Sep 30, 2026.
How has the price of PHYTONADIONE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHYTONADIONE 5 MG TABLET has declined 60.8%. It has been tracked across 122 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for PHYTONADIONE 5 MG TABLET?
Since Jun 5, 2024, the NADAC for PHYTONADIONE 5 MG TABLET has ranged from a low of $8.8257 (Sep 23, 2026) to a high of $22.5154 (Jun 12, 2024), with a median of $11.8169 per EA.
Are there cheaper alternatives to PHYTONADIONE 5 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHYTONADIONE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PHYTONADIONE 5 MG TABLET?
PHYTONADIONE 5 MG TABLET (NDC 69097099902) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.